糖尿病患者低血糖影响生活质量的患者报告结局测量工具适用性:基于COSMIN方法的系统综述
该系统综述旨在识别用于评估低血糖对糖尿病患者生活质量影响的患者报告结局测量工具(PROMs),并依据COSMIN指南评估其质量和心理测量学特性。共识别出7个低血糖特异性PROMs,其内容效度被评为不一致且多为低至极低质量,结构效度不满意。结论认为现有PROMs均缺乏足够证据证明其有效性、可靠性和反应性,限制了临床和研究应用。
要点
- 共识别7个低血糖特异性PROMs,均缺乏充分的有效性、可靠性和反应性证据。
- 内容效度多评为低至极低质量,结构效度不满意。
- 所有PROMs均未涉及跨文化效度和测量误差。
核心结论
- 现有低血糖特异性PROMs均无足够证据证明其有效性、可靠性和反应性满足要求。
- 所有PROMs在内容效度和结构效度方面存在局限,限制了其在临床或研究中的应用。
研究设计与样本
- 系统检索MEDLINE、EMBASE、PsycINFO、CINAHL和Cochrane Library数据库,方案注册于PROSPERO(CRD42019125153)。
- 纳入报告低血糖特异性PROMs开发或验证的已发表文章,对象为成人糖尿病患者。
- 由两名评价者独立依据COSMIN指南提取数据并评估PROMs。
- 内容效度评估包括16名评审者(研究者6名、临床医生6名、成人糖尿病患者4名)对相关性、全面性和可理解性的评分。
主要发现
- 共识别214个用于评估低血糖对生活质量影响的PROMs,其中7个为低血糖特异性PROMs并接受全面评估。
- 7个PROMs包括:Fear of Hypoglycemia 15-item scale、Hypoglycemia Fear Survey、Hypoglycemia Fear Survey version II、Hypoglycemia Fear Survey-II short-form、Hypoglycemic Attitudes and Behavior Scale、Hypoglycemic Confidence Scale和QoLHYPO问卷。
- 内容效度评为不一致,多数为低至极低质量;结构效度 deemed unsatisfactory。
- 其他测量属性(如信度)参差不齐,所有PROMs均存在证据缺口。
- 无研究涉及跨文化效度或测量误差;由于缺乏金标准,未评估效标效度和反应性。
关键数值与推荐
- 内容效度评审采用16名评审者(研究者6名、临床医生6名、成人糖尿病患者4名)对相关性、全面性和可理解性进行评分。
- 结构效度被评为不满意,内容效度评为不一致且多数为低至极低质量。
临床怎么用
- 现有低血糖特异性PROMs因内容和结构效度局限,尚不适合常规用于临床或研究中评估低血糖对生活质量的影响。
- 临床选择PROMs时需谨慎,应优先考虑测量属性证据更充分的工具。
局限性
- 缺乏低血糖对生活质量影响的金标准测量工具,无法评估效标效度和反应性。
- 所有PROMs均未报告跨文化效度和测量误差数据。
- 内容效度评估中评审者数量有限(共16名)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS/HYPOTHESIS: It is generally accepted that hypoglycaemia can negatively impact the quality of life (QoL) of people living with diabetes. However, the suitability of patient-reported outcome measures (PROMs) used to assess this impact is unclear. The aim of this systematic review was to identify PROMs used to assess the impact of hypoglycaemia on QoL and examine their quality and psychometric properties. METHODS: Systematic searches (MEDLINE, EMBASE, PsycINFO, CINAHL and The Cochrane Library databases) were undertaken to identify published articles reporting on the development or validation of hypoglycaemia-specific PROMs used to assess the impact of hypoglycaemia on QoL (or domains of QoL) in adults with diabetes. A protocol was developed and registered with PROSPERO (registration no. CRD42019125153). Studies were assessed for inclusion at title/abstract stage by one reviewer. Full-text articles were scrutinised where considered relevant or potentially relevant or where doubt existed. Twenty per cent of articles were assessed by a second reviewer. PROMS were evaluated, according to COnsensus-based Standards for the selection of health Measurement INstruments (COSMIN) guidelines, and data were extracted independently by two reviewers against COSMIN criteria. Assessment of each PROM's content validity included reviewer ratings (N = 16) of relevance, comprehensiveness and comprehensibility: by researchers (n = 6); clinicians (n = 6); and adults with diabetes (n = 4). RESULTS: Of the 214 PROMs used to assess the impact of hypoglycaemia on QoL (or domains of QoL), seven hypoglycaemia-specific PROMS were identified and subjected to full evaluation: the Fear of Hypoglycemia 15-item scale; the Hypoglycemia Fear Survey; the Hypoglycemia Fear Survey version II; the Hypoglycemia Fear Survey-II short-form; the Hypoglycemic Attitudes and Behavior Scale; the Hypoglycemic Confidence Scale; and the QoLHYPO questionnaire. Content validity was rated as 'inconsistent', with most as '(very) low' quality, while structural validity was deemed 'unsatisfactory'. Other measurement properties (e.g. reliability) varied, and evidence gaps were apparent across all PROMs. None of the identified studies addressed cross-cultural validity or measurement error. Criterion validity and responsiveness were not assessed due to the lack of a 'gold standard' measure of the impact of hypoglycaemia on QoL against which to compare the PROMS. CONCLUSIONS/INTERPRETATION: None of the hypoglycaemia-specific PROMs identified had sufficient evidence to demonstrate satisfactory validity, reliability and responsiveness. All were limited in terms of content and structural validity, which restricts their utility for assessing the impact of hypoglycaemia on QoL in the clinic or research setting. Further research is needed to address the content validity of existing PROMs, or the development of new PROM(s), for the purpose of assessing the impact of hypoglycaemia on QoL. PROSPERO REGISTRATION: CRD42019125153.
引用
- Carlton J, Leaviss J, Pouwer F, et al. The suitability of patient-reported outcome measures used to assess the impact of hypoglycaemia on quality of life in people with diabetes: a systematic review using COSMIN methods. Diabetologia. 2021. PMID: 33528625. doi:10.1007/s00125-021-05382-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。